Amgen officially buys the rights for some of Unilife’s drug delivery devices for $75M
The collaboration between Amgen and Unilife is apparently now official. Amgen announced that for a lifeline worth up to $75 million, it has exclusive rights to a select group of Unilife's wearable injectors.